$49.03
2.12% yesterday
Nasdaq, Jun 11, 10:00 pm CET
ISIN
US40131M1099
Symbol
GH

Guardant Health, Inc. Stock price

$49.03
+7.37 17.69% 1M
+13.37 37.49% 6M
+18.48 60.49% YTD
+18.53 60.75% 1Y
-27.41 35.86% 5Y
+16.83 52.27% 10Y
+16.83 52.27% 20Y
Nasdaq, Closing price Wed, Jun 11 2025
-1.06 2.12%
ISIN
US40131M1099
Symbol
GH
Sector

Key metrics

Market capitalization $6.07b
Enterprise Value $6.49b
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 8.39
P/S ratio (TTM) P/S ratio 7.85
P/B ratio (TTM) P/B ratio negative
Revenue growth (TTM) Revenue growth 28.20%
Revenue (TTM) Revenue $774.00m
EBIT (operating result TTM) EBIT $-454.70m
Free Cash Flow (TTM) Free Cash Flow $-305.53m
Cash position $698.57m
EPS (TTM) EPS $-3.36
P/E forward negative
P/S forward 6.86
EV/Sales forward 7.34
Short interest 7.73%
Show more

Is Guardant Health, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,842 stocks worldwide.

Guardant Health, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

26 Analysts have issued a Guardant Health, Inc. forecast:

22x Buy
85%
3x Hold
12%
1x Sell
4%

Analyst Opinions

26 Analysts have issued a Guardant Health, Inc. forecast:

Buy
85%
Hold
12%
Sell
4%

Financial data from Guardant Health, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
774 774
28% 28%
100%
- Direct Costs 299 299
25% 25%
39%
475 475
30% 30%
61%
- Selling and Administrative Expenses 577 577
27% 27%
75%
- Research and Development Expense 352 352
2% 2%
46%
-414 -414
20% 20%
-53%
- Depreciation and Amortization 41 41
6% 6%
5%
EBIT (Operating Income) EBIT -455 -455
19% 19%
-59%
Net Profit -417 -417
10% 10%
-54%

In millions USD.

Don't miss a Thing! We will send you all news about Guardant Health, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Guardant Health, Inc. Stock News

Neutral
Business Wire
2 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced its Shield blood test for colorectal cancer (CRC) screening has been named a winner of Fast Company's 2025 World Changing Ideas Awards. These annual awards recognize innovative companies and projects addressing the world's most urgent challenges. Shield is the first bloo...
Neutral
Business Wire
3 days ago
PALO ALTO, Calif.--(BUSINESS WIRE)--Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced results from the LIBERATE study published in ESMO Open. The results in the peer-reviewed manuscript demonstrate the clinical validity and high performance of Guardant Reveal, the company's minimal residual disease (MRD) blood test, in predicting recurrence in patients wi...
Positive
The Motley Fool
9 days ago
Precision oncology specialist Guardant Health (GH 8.53%) was something of a stock market star on Tuesday. On the back of very positive news in the regulatory sphere, the company's shares jumped almost 9% higher today.
More Guardant Health, Inc. News

Company Profile

Guardant Health, Inc. is a precision oncology company, which engages in treatment of cancer through use of proprietary blood-based tests, vast data sets, and advanced analytics. Its solutions include treatment selection, recurrence detection, and early detection. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Redwood City, CA.

Head office United States
CEO Helmy Eltoukhy
Employees 2,010
Founded 2012
Website guardanthealth.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today